Binder profile

ZINC1684489

Virtual-screening candidate from ZINC.

Bound to: PA3088 — NAD kinase

Via homolog UniProt Q8Y8D7 C13H20N5O+
Tanimoto 0.67
Mol. weight 262.34 Da
Permeability High
PAINS Clean

Identifiers

Database identifiers and provenance.

Ligand ID
ZINC1684489
UniProt (similar protein)
Q8Y8D7
Tanimoto
0.674
Target protein
PA3088

Structure

2D representation rendered from SMILES.

Physicochemical properties

Computed with RDKit from SMILES.

Molecular weight 262.34 Da
LogP (Crippen) 1.72
H-bond donors 0
H-bond acceptors 5
TPSA 52.83 Ų
Rotatable bonds 2
Aromatic rings 2 / 3
Heavy atoms 19
Fraction sp³ C 0.62
Formula C13H20N5O+

Drug-likeness

Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.

Permeability proxy High

Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.

Lipinski's Rule of Five Pass 0 violations
  • MW ≤ 500 Da 262.3
  • LogP ≤ 5 1.72
  • H-bond donors ≤ 5 0
  • H-bond acceptors ≤ 10 5
Veber's rules Pass
  • Rotatable bonds ≤ 10 2
  • TPSA ≤ 140 Ų 52.8
PAINS Clean

No PAINS structural alerts detected.

Chemical representations

Canonical representations for cheminformatics workflows.

SMILES 
C[N+](C)(C)c1ncnc2c1ncn2[C@H]1CCCCO1
InChI 
InChI=1S/C13H20N5O/c1-18(2,3)13-11-12(14-8-15-13)17(9-16-11)10-6-4-5-7-19-10/h8-10H,4-7H2,1-3H3/q+1/t10-/m1/s1
InChIKey 
CSZQANOPEOXSKZ-SNVBAGLBSA-N

Provenance

Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.

Method
LigQ nearest_k
Query
KF5
Homolog
Q8Y8D7

External resources

Open this ligand in third-party databases and cheminformatics tools.

Other binders for this protein

Quick navigation to other ligands bound to PA3088.

PDB 52

Ligands co-crystallized with this protein (structural evidence).

Ligand PDB entry

ChEMBL 3

Compounds with measured inhibitory activity on this target (higher pchembl = more potent).

Compound Potency (pchembl)

ZINC 49

Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).

Compound Similarity (Tanimoto)